- Home
- HODO vs NVNO Comparison
HODO vs NVNO Comparison
Compare HODO & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HODO | NVNO |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | 33 |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 7.2M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | HODO | NVNO |
|---|---|---|
| Price | $1.70 | $11.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 86.2K | 6.4K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $140.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.22 | $0.30 |
| 52 Week High | $2.52 | $13.44 |
Technical Indicators
Market Signals| Indicator | HODO | NVNO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.07 |
| Support Level | N/A | $9.78 |
| Resistance Level | N/A | $11.15 |
| Average True Range (ATR) | 0.00 | 0.77 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 0.00 | 50.78 |
Price Performance
Historical ComparisonAbout NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.